Institute of Oncology Prof. Dr. Ion Chiricuta

Cluj-Napoca RO-400015

2 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, Breast Cancer, Metastatic Non Small Cell Lung Cancer, NF1 Mutation, RAF Mutation, RAS Mutation

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
• PAS-004 in Patients With Advanced Solid Tumors — Recruiting now
• Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) — Running, not enrolling